Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Free Report) Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction dated Friday, January 17th. The stock was sold at an average price of $67.15, for a total value of $2,350,250.00. Following the sale, the director now directly owns 25,809 shares in the company, valued at approximately $1,733,074.35. This trade represents a 57.56 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Nicholas Dominic Cortezi also recently made the following trade(s):
- On Tuesday, January 21st, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.35, for a total value of $2,322,250.00.
- On Wednesday, January 15th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.99, for a total value of $2,309,650.00.
- On Monday, January 13th, Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock. The stock was sold at an average price of $65.06, for a total transaction of $1,917,057.96.
- On Friday, December 20th, Nicholas Dominic Cortezi sold 91 shares of Ryan Specialty stock. The shares were sold at an average price of $65.00, for a total transaction of $5,915.00.
- On Wednesday, December 18th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $65.17, for a total transaction of $2,280,950.00.
- On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $66.71, for a total transaction of $2,334,850.00.
- On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $67.39, for a total value of $2,358,650.00.
Ryan Specialty Stock Down 1.6 %
NYSE:RYAN opened at $65.66 on Thursday. The company has a market cap of $17.19 billion, a price-to-earnings ratio of 85.27, a P/E/G ratio of 1.16 and a beta of 0.72. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The stock’s fifty day moving average price is $67.63 and its two-hundred day moving average price is $66.12. Ryan Specialty Holdings, Inc. has a 52-week low of $42.21 and a 52-week high of $75.97.
Ryan Specialty Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were paid a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 0.67%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.
Analyst Ratings Changes
RYAN has been the topic of several recent analyst reports. Barclays boosted their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. Keefe, Bruyette & Woods reduced their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research note on Friday, January 10th. The Goldman Sachs Group increased their target price on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. Morgan Stanley began coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target on the stock. Finally, Wells Fargo & Company dropped their price objective on shares of Ryan Specialty from $68.00 to $64.00 and set an “equal weight” rating for the company in a report on Tuesday, January 14th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $74.40.
Get Our Latest Analysis on Ryan Specialty
Institutional Investors Weigh In On Ryan Specialty
A number of institutional investors and hedge funds have recently modified their holdings of the business. Principal Financial Group Inc. grew its holdings in Ryan Specialty by 148.9% during the 3rd quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock worth $56,545,000 after acquiring an additional 509,548 shares during the period. Jennison Associates LLC grew its stake in shares of Ryan Specialty by 60.2% during the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock worth $68,054,000 after purchasing an additional 385,366 shares during the period. Eagle Asset Management Inc. increased its holdings in Ryan Specialty by 32.1% in the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock valued at $98,555,000 after purchasing an additional 335,180 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Ryan Specialty by 43.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock valued at $62,286,000 after purchasing an additional 286,380 shares during the last quarter. Finally, Driehaus Capital Management LLC bought a new position in Ryan Specialty during the second quarter worth about $16,313,000. 84.82% of the stock is owned by institutional investors.
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading
- Five stocks we like better than Ryan Specialty
- Stock Splits, Do They Really Impact Investors?
- Oracle Announces Game-Changing News for the AI Industry
- Which Wall Street Analysts are the Most Accurate?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Basic Materials Stocks Investing
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.